-
Very long time persistent hyperCKemia as the first manifestation of McLeod syndrome
-
Video-guided Optimization of Stimulation Settings in Patients with Parkinson’s Disease and Deep Brain Stimulation
-
Video-oculographic biomarkers for evaluating vertical ocular dysfunction in progressive supranuclear palsy
-
Virtual Visit Experience of the Portland Oregon Pacific UDALL Center During COVID-19
-
Visual Hallucinations and Parkinson’s Disease Neuropathology among Decedents with and without Parkinson’s Disease or Lewy Body Dementia During Life
-
Visual system abnormalities and visual hallucinations in Parkinson’s disease
-
Visualising cholinergic nerves in dementia with Lewy bodies using PET and FEOBV
-
Visuospatial deficits characterize Pisa syndrome and not Camptocormia in Parkinson’s disease
-
Vodobatinib, a potent, orally bioavailable brain-penetrating inhibitor of c-Abl as a potential neuroprotective agent for the treatment of Parkinson’s Disease
-
Volumetric analysis of the Corpus Callosum in Hereditary Cerebellar Ataxia
2022 International Congress
September 15-18, 2022. Madrid, Spain.